非酒精性脂肪肝与中年健康成人脑体积减小的关联:Framingham研究
该横断面研究纳入Framingham后代队列766名无卒中及痴呆的参与者,评估非酒精性脂肪肝(NAFLD)与脑MRI指标的关系。结果显示NAFLD与总脑体积较小独立相关,相当于脑老化4.2年(<60岁者7.3年),但与海马体积、白质高信号体积或隐匿性脑梗死无显著关联。
要点
- NAFLD与总脑体积较小独立相关,独立于内脏脂肪和心血管代谢危险因素。
- NAFLD患者总脑体积差异相当于脑老化4.2年,60岁以下者相当于7.3年。
- NAFLD与海马体积、白质高信号体积及隐匿性脑梗死无显著关联。
核心结论
- NAFLD与总脑体积较小独立相关,提示肝脂肪变性可能与脑老化有关。
研究设计与样本
- 横断面研究,纳入Framingham后代队列766名无过量饮酒、卒中及痴呆的参与者(410名女性,356名男性;脑MRI时平均年龄67岁)。
- NAFLD通过腹部多排CT评估。
- 采用线性或逻辑回归模型分析NAFLD与脑MRI指标的关联,并调整年龄、性别、饮酒、内脏脂肪、BMI、收缩压、高血压、吸烟、HDL和LDL胆固醇、降脂治疗、2型糖尿病、心血管疾病、体力活动、胰岛素抵抗、C反应蛋白及血浆同型半胱氨酸等协变量。
主要发现
- 766名参与者中137名(17.9%)患有NAFLD。
- NAFLD与总脑体积较小显著相关(β [SE], -0.26 [0.11]; P = .02),即使调整所有协变量后仍显著。
- NAFLD与无NAFLD者总脑体积差异相当于一般样本脑老化4.2年,60岁以下者相当于7.3年。
- NAFLD与海马体积、白质高信号体积或隐匿性脑梗死无统计学显著关联。
临床怎么用
- 在中年健康人群中,NAFLD可能提示脑体积减小风险,需关注肝脂肪变性对脑老化的潜在影响。
- 对于NAFLD患者,即使无卒中或痴呆,也应考虑脑健康评估和心血管代谢危险因素管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Nonalcoholic fatty liver disease (NAFLD) is a common condition that is most often asymptomatic. It is associated with metabolic syndrome, incident diabetes, carotid atherosclerosis, and endothelial dysfunction, conditions that in turn are strongly linked with brain damage and cognitive impairment. However, it is not known whether NAFLD is associated with structural brain measures in humans. OBJECTIVE: To assess the association between prevalent NAFLD and brain magnetic resonance imaging (MRI) measures. DESIGN, SETTING, AND PARTICIPANTS: The cross-sectional association between NAFLD and brain MRI measures was assessed from November 6, 2002, to March 16, 2011, in 766 individuals from the Offspring cohort of the Framingham Study. Participants were included if they did not have excessive alcohol intake and were free of stroke and dementia. Data analysis was conducted from December 30, 2015, to June 15, 2016. EXPOSURES: Nonalcoholic fatty liver disease was assessed by multidetector computed tomographic scans of the abdomen. MAIN OUTCOMES AND MEASURES: Linear or logistic regression models were used to evaluate the cross-sectional association between NAFLD and brain MRI measures, adjusting for age, sex, alcohol consumption, visceral adipose tissue, body mass index, menopausal status, systolic blood pressure, hypertension, current smoking, high-density lipoprotein and low-density lipoprotein cholesterol levels, lipid treatment, type 2 diabetes, cardiovascular disease, physical activity, insulin resistance, C-reactive protein levels, and plasma homocysteine values. Brain MRI measures included total cerebral brain volume, hippocampal and white matter hyperintensity volumes, and presence or absence of covert brain infarcts. RESULTS: Of the 766 individuals in the study sample (410 women and 356 men; mean [SD] age at the time of brain MRI, 67 [9] years), 137 (17.9%) had NAFLD. Nonalcoholic fatty liver disease was significantly associated with smaller total cerebral brain volume even after adjustment for all the covariates included in the study (β [SE], -0.26 [0.11]; P = .02). Differences in total cerebral brain volume between those with and without NAFLD corresponded to 4.2 years of brain aging in the general sample and to 7.3 years in individuals younger than 60 years of age. No statistically significant associations were observed between NAFLD and hippocampal or white matter hyperintensity volumes or covert brain infarcts. CONCLUSIONS AND RELEVANCE: Nonalcoholic fatty liver disease is associated with a smaller total cerebral brain volume, independent of visceral adipose tissue and cardiometabolic risk factors, pointing to a possible link between hepatic steatosis and brain aging.
引用
- Weinstein G, Zelber-Sagi S, Preis SR, et al. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. JAMA Neurol. 2018. PMID: 29159396. doi:10.1001/jamaneurol.2017.3229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。